Copy
Canadian Deprescribing Network newsletter—November edition: On why Canada needs a national medication appropriateness strategy.

Why Canada needs a national strategy on medication appropriateness: watch our recent panel presentation

Earlier this month, Canadian Deprescribing Network drug policy experts teamed up to present at the Canadian Agency for Drugs & Technologies in Health (CADTH) 2021 Virtual Symposium. Their presentation, "Improving the Appropriate Use of Medications Across Canada: Translating International Health Policy Evidence to the Canadian Context," is now available online. View and share to help spark action!

The presentation addresses the following themes:

  1. The Canadian landscape: variations in provincial prescribing patterns and policies explaining this variation;
  2. Lessons from abroad: Existing policies that promote appropriate medication use in Australia, England and Sweden, and their impact;

  3. Discussion: A national medication appropriateness strategy must be embedded in the structure and functioning of a future Canadian Drug Agency—but how do we implement best practices?

The time is now.

As we move forward towards a Canadian Drug Agency—a national body with the capacity to improve access, affordability and appropriateness of prescription medications for all Canadians—issues of drug access and affordability are often discussed. The Canadian Deprescribing Network is calling on policymakers to make appropriate use of medications a priority.

We hope we've piqued your curiosity! We encourage you to contact us with your comments or questions about this topic!
 
Click here to learn more about our proposed medication appropriateness strategy

 

Have you heard about this research project?
Project GPS: Optimizing medication use in older adults to promote aging in place


The recent integration of pharmacists in Family Medicine Groups (FMG) in the province of Quebec alongside pharmacists' expanded scope of practice creates new opportunities to promote interdisciplinary collaboration and optimize medication use in older adults.

Project GPS is funded by the Fonds de recherche du Québec – Santé and led by researchers from Laval University. The project aims to evaluate the impact of the above-mentioned changes on older adults residing in the community who are undergoing cognitive assessment or who are living with a major neurocognitive disorder. This project is currently underway in Family Medicine Groups in the regions of Chaudière-Appalaches and Nord-de-l’Île-de-Montréal in Quebec.

 
For more information, visit this website.
*Please note this website is in French only.

Always talk to your doctor, nurse or pharmacist before stopping or making changes to any of your medications.

The Canadian Deprescribing Network is a group of healthcare leaders, clinicians, decision-makers, academic researchers and patient advocates working together to mobilize knowledge and promote the deprescribing of medication that may no longer be of benefit or that may be causing harm.

The Canadian Deprescribing Network is committed to eliminating the use of potentially inappropriate medications for Canadian seniors and ensuring access to safer drug and non-drug therapies.

To learn more, visit DeprescribingNetwork.ca
Not yet signed up for our newsletter?
Subscribe here!
Website
Twitter
Facebook
Copyright © 2021 Centre de recherche de l'Institut universitaire de gériatrie de Montréal, All rights reserved.


Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list